- Home
- SFHG vs CARM Comparison
SFHG vs CARM Comparison
Compare SFHG & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFHG
- CARM
- Stock Information
- Founded
- SFHG 1993
- CARM 2016
- Country
- SFHG Hong Kong
- CARM United States
- Employees
- SFHG N/A
- CARM N/A
- Industry
- SFHG Publishing
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- SFHG Consumer Discretionary
- CARM Health Care
- Exchange
- SFHG Nasdaq
- CARM Nasdaq
- Market Cap
- SFHG 14.9M
- CARM 12.1M
- IPO Year
- SFHG 2024
- CARM N/A
- Fundamental
- Price
- SFHG N/A
- CARM $0.27
- Analyst Decision
- SFHG
- CARM Hold
- Analyst Count
- SFHG 0
- CARM 5
- Target Price
- SFHG N/A
- CARM $0.90
- AVG Volume (30 Days)
- SFHG 62.3K
- CARM 1.2M
- Earning Date
- SFHG 04-16-2025
- CARM 11-06-2025
- Dividend Yield
- SFHG N/A
- CARM N/A
- EPS Growth
- SFHG N/A
- CARM N/A
- EPS
- SFHG N/A
- CARM N/A
- Revenue
- SFHG $19,760,935.00
- CARM $10,767,000.00
- Revenue This Year
- SFHG N/A
- CARM N/A
- Revenue Next Year
- SFHG N/A
- CARM N/A
- P/E Ratio
- SFHG N/A
- CARM N/A
- Revenue Growth
- SFHG 30.89
- CARM N/A
- 52 Week Low
- SFHG $0.55
- CARM $0.14
- 52 Week High
- SFHG $24.00
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- SFHG 35.03
- CARM 45.55
- Support Level
- SFHG $0.64
- CARM $0.24
- Resistance Level
- SFHG $0.71
- CARM $0.27
- Average True Range (ATR)
- SFHG 0.04
- CARM 0.03
- MACD
- SFHG -0.01
- CARM -0.00
- Stochastic Oscillator
- SFHG 8.87
- CARM 44.15
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.